Cargando…
Factor VLeiden and Prothrombin G20210A Gene Polymorphisms in Patients with Coronary Artery Disease
PURPOSE: The precise molecular mechanisms culminating in coronary artery disease (CAD) are not well understood, despite a wealth of knowledge on predisposing risk factors and pathomechanisms. CAD and myocardial infarction (MI) are complex genetic diseases; neither the environment alone, nor a single...
Autores principales: | Ercan, Bahadır, Tamer, Lülüfer, Sucu, Nehir, Pekdemir, Hasan, Çamsarı, Ahmet, Atik, Uğur |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615327/ https://www.ncbi.nlm.nih.gov/pubmed/18452260 http://dx.doi.org/10.3349/ymj.2008.49.2.237 |
Ejemplares similares
-
Prothrombin Gene G20210A Variant in Angiographically Documented Patients with Coronary Artery Stenosis
por: Pourgholi, Leyla, et al.
Publicado: (2019) -
Epidemiology of Prothrombin G20210A Mutation in the Mediterranean Region
por: Jadaon, Mehrez M.
Publicado: (2011) -
Genetic correlation between Prothrombin G20210A polymorphism and retinal vein occlusion risk
por: Zou, Yuanyuan, et al.
Publicado: (2019) -
The impact of prothrombin (G20210A) gene mutation on stroke in youths
por: Saadatnia, Mohammad, et al.
Publicado: (2012) -
Prevalence of the prothrombin G20210A mutation among ischemic stroke patients
por: Ahmed, Salar A., et al.
Publicado: (2020)